A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Clinical trial NCT01479868 · COMPLETED
Trial details
- NCT number
- NCT01479868
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-08-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.